Search

Your search keyword '"Hydroxychloroquine therapeutic use"' showing total 3,544 results

Search Constraints

Start Over You searched for: Descriptor "Hydroxychloroquine therapeutic use" Remove constraint Descriptor: "Hydroxychloroquine therapeutic use"
3,544 results on '"Hydroxychloroquine therapeutic use"'

Search Results

1. Beneficial effects of hydroxychloroquine on blood lipids and glycated haemoglobin: A randomised interventional study in patients with rheumatoid arthritis and systemic lupus erythematosus.

2. Clinical characteristics, treatment and outcome of subacute cutaneous lupus erythematosus induced by PD-1/PD-L1 inhibitors.

3. Systemic lupus erythematosus with podocyte infolding glomerulopathy: A case report and literature review.

4. StratosPHere 2: study protocol for a response-adaptive randomised placebo-controlled phase II trial to evaluate hydroxychloroquine and phenylbutyrate in pulmonary arterial hypertension caused by mutations in BMPR2.

5. Liver fibrosis in inflammatory arthritis patients treated with methotrexate and hydroxychloroquine: A FIB-4 index analysis.

6. Trametinib in combination with hydroxychloroquine or palbociclib in advanced metastatic pancreatic cancer: data from a retrospective, multicentric cohort (AIO AIO-TF/PAK-0123).

8. Treatment of lichen sclerosus with hydroxychloroquine: a Mayo Clinic experience.

9. Hydroxychloroquine and Pre-eclampsia in a Diverse Cohort of Women With Systemic Lupus Erythematosus.

10. Prevalence, Outcomes, and Predictors of Prolonged Corrected QT Interval in Hydroxychloroquine-Naïve Hospitalized COVID-19 Patients.

11. Hydroxychloroquine Improves Low Complement Levels.

12. Investigating corrected QT prolongation with hydroxychloroquine use among patients with cutaneous sarcoidosis: A multicenter retrospective study.

13. Retinal Vasculitis in a Patient with Rhupus.

14. Treatment patterns in patients with systemic lupus erythematosus in New Zealand.

15. Hydroxychloroquine Dose and Hospitalizations for Active Lupus.

16. Taking hydroxychloroquine to heart.

17. Efficacy of antimalarials in oral lichen planus: A systematic review.

18. Real-world treatment patterns in patients with systemic lupus erythematosus: associations with comorbidities and damage.

19. Haemolysis index conundrum in a COVID-19 patient.

20. Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.

21. Hydroxychloroquine as an Adjunct Therapy for Diabetes in Pregnancy.

22. Dialogue: Antiplatelet effects of hydroxychloroquine in patients with systemic lupus erythematosus evaluated by the total thrombus-formation analysis system (T-TAS).

23. Hydroxychloroquine and a low antiresorptive activity bisphosphonate conjugate prevent and reverse ovariectomy-induced bone loss in mice through dual antiresorptive and anabolic effects.

24. Case report: membranoproliferative glomerulonephritis associated with Q fever causing chronic endocarditis.

25. Mycophenolate Mofetil and New-Onset Systemic Lupus Erythematosus: A Randomized Clinical Trial.

26. Efficacy and safety of methotrexate plus hydroxychloroquine combination therapy vs. methotrexate monotherapy in the treatment of rheumatoid arthritis: A randomized controlled clinical trial.

27. Slate Grey Eyelid Pigmentation in a Patient With Hemochromatosis and Prior Hydroxychloroquine Use.

28. IgG4-associated disease with systemic lupus erythematosus: A case report and review.

29. Antiphospholipid antibodies as potential prognostic indicators of recurrent ischemic stroke.

30. Iguratimod suppresses plasma cell differentiation and ameliorates experimental Sjögren's syndrome in mice by promoting TEC kinase degradation.

31. Challenges and Reflections on Pandemic Disinformation: The Case of Hydroxychloroquine and the Implications for Global Public Health.

32. Hydroxychloroquine-induced acute generalized exanthematous pustulosis (AGEP) treated with secukinumab.

33. Lipodystrophia centrifugalis abdominals infantilis presenting as a giant ulceration and treatment with hydroxychloroquine and baricitinib.

34. Hydroxychloroquine in recurrent pregnancy loss: data from a French prospective multicenter registry.

36. Low dose glucocorticoids, mycophenolate mofetil and hydroxychloroquine in IgA nephropathy, an update of current clinical trials.

37. Bilateral outer foveal microdefect in a patient with systemic lupus erythematosus using hydroxychloroquine - A case report.

38. Descriptions of Scientific Evidence and Uncertainty of Unproven COVID-19 Therapies in US News: Content Analysis Study.

39. The evaluation of the short-term and long-term hydroxychloroquine therapy on ECG parameters.

40. Hydroxychloroquine and Cardiovascular Events in Patients With Systemic Lupus Erythematosus.

41. Hydroxychloroquine, Chloroquine, and Arrhythmic Risk in Systemic Autoimmune Diseases: Focus More on the Patient and You Will Keep the Rhythm!

42. COVID-19 and autoimmune rheumatic disease: behavioural changes adopted by patients amid the pandemic.

43. Antiphospholipid Syndrome Nephropathy Occurs in Pregnancy: A Case Report.

44. Incident Use of Hydroxychloroquine for the Treatment of Rheumatoid Arthritis and Systemic Lupus Erythematosus During the COVID-19 Pandemic.

45. [Kidney diseases: News from the KDIGO guidelines].

46. [EULAR recommendations 2023 on the treatment of systemic lupus erythematosus -Implications for treatment in Germany].

47. Hydroxychloroquine and risk of osteoporosis in patients with rheumatoid arthritis: A population-based retrospective study of 6408 patients.

48. Effect of antimalarials on clinical outcomes in lupus nephritis.

49. Treatment of persistent focalized Q fever: time has come for an international randomized controlled trial.

50. [What is proven in the treatment of systemic lupus erythematosus?]

Catalog

Books, media, physical & digital resources